1. Market Research
  2. > Cancer Industry

Leukemia Industry, August 2016 Market Reports from Top Publishers

You might be interested in: Molecular Diagnostic, Diagnostics, Cancer, Therapy, Blood Disease, Blood Supply, Pap Smear, Anti-Infective, Bone Marrow Transplant, Cancer Diagnostic, Clinical Trial, In Vitro Diagnostic Reagent, Stem Cell.


 
1-10 of about 300 reports for Leukemia

Purchase Reports From Reputable Market Research Publishers

Target Atlas in Hematological Cancers: A Competitive Outlook

Target Atlas in Hematological Cancers: A Competitive Outlook

  • $ 3 540
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product "Target Atlas in Hematological Cancers: A Competitive Outlook" helps you to understand the complex world of commercial development ...

Leukemia: Analytical Tool

Leukemia: Analytical Tool

  • $ 7 125
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Target Atlas in Leukemia: A Competitive Outlook

Target Atlas in Leukemia: A Competitive Outlook

  • $ 2 700
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product "Target Atlas in Leukemia: A Competitive Outlook" helps you to understand the complex world of commercial development in leukemia ...

Leukemia Drug Pathway Analyzer

Leukemia Drug Pathway Analyzer

  • $ 2 700
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 620 targeted molecular therapies known to affect more than 248 specific intracellular signaling pathways ...

Leukemia Drug Pipeline Update

Leukemia Drug Pipeline Update

  • $ 2 700
  • Company report
  • August 2016
  • by Bioseeker

Leukemia includes a broad variety of histological separate disorders which make the leukemia market segmented. There are today 456 companies plus partners developing 631 leukemia drugs in 913 developmental ...

Treatment of Acute Myeloid Leukemia (AML) - Patent Overview in the years 2011 - 2016

Treatment of Acute Myeloid Leukemia (AML) - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Myelodysplastic syndromes are a group of disorders caused by poorly formed or dysfunctional blood cells. Myelodysplastic syndromes occur when something goes wrong in your bone marrow — the spongy material ...

Treatment of Acute Lymphoblastic Leukemia - Patent Overview in the years 2011 - 2016

Treatment of Acute Lymphoblastic Leukemia - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

This patent report provides a statistical overview of the specified technology/segment for the last five years.The claimed technology in the patent is segmented categorically and is the basis for insights ...

Treatment of Acute Myeloid Leukemia - Patent Overview in the years 2011 - 2016 - Patent Overview in the years 2011 - 2016

Treatment of Acute Myeloid Leukemia - Patent Overview in the years 2011 - 2016 - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Acute lymphocytic leukemia (ALL) is a type of cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made. Acute lymphocytic leukemia is the most common type of cance ...

 B-Cell Leukemia-Pipeline Insights, 2016

B-Cell Leukemia-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ B-Cell Leukemia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the B-Cell Leukemia. The Delv ...

 Refractory Leukemia-Pipeline Insights, 2016

Refractory Leukemia-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Refractory Leukemia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Refractory Leukemia. The ...

About 4 800 reports for Leukemia

Download Unlimited Documents from Trusted Public Sources

Blood Disease Statistics and Leukemia Statistics

  • January 2014
    265 pages
  • Blood Disease  

    Leukemia  

    Lymphoma  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.